Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results


1.		EUS-CPN in Unresectable Pancreatic Cancer: a Pilot Study

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Closed				18 and over				Other				0702-25 IRB # 0702-25, Clarian Values Grant: vfr-262, NCT00578279

Last Modified: 5/1/2001 First Published: 11/1/1997


2.		Phase II Study of Perillyl Alcohol (POH) in Patients with Recurrent or Refractory Epithelial Ovarian Cancer (Summary Last Modified 05/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				E-2E96 E2E96

Last Modified: 9/25/2007 First Published: 4/1/1998


3.		Phase II Study of Perillyl Alcohol in Patients with Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				WCCC-CO-9611 NCI-T97-0068, NCT00003219, T97-0068

Last Modified: 4/1/2001 First Published: 4/1/1998


4.		Phase II Study of Perillyl Alcohol in Patients with Metastatic Androgen Independent Prostate Cancer (Summary Last Modified 04/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				Not specified				NCI				WCCC-CO-9685 NCI-T97-0067, NCT00003238, T97-0067

Last Modified: 6/27/2006 First Published: 3/1/1999


5.		Phase II Study of Perillyl Alcohol in Patients With Resectable, Stage II or Stage III Pancreatic Adenocarcinoma (Summary Last Modified 10/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				IUMC-9710-07 NCI-T98-0046, NCT00003769

Last Modified: 1/1/2000 First Published: 5/1/1999


6.		Phase II Study of Perillyl Alcohol in Patients with Metastatic Adenocarcinoma of the Colon or Rectum (Summary Last Modified 01/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				WCCC-CO-98202 NCI-T98-0044, T98-0044

Last Modified: 2/1/1998


7.		Phase I Study of Daily Oral Perillyl Alcohol for Advanced Solid Tumors (Summary Last Modified 02/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				WCCC-CO-9591 NCI-T95-0006H, T95-0006

Last Modified: 9/1/2000


8.		Phase I Study of Perillyl Alcohol in Patients With Refractory Malignancies (Summary Last Modified 09/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				over 18				NCI				YALE-HIC-8895 NCI-T96-0064D, NCT00002862, T96-0064

Last Modified: 4/1/1998


9.		Phase IA/IB Trial of Perillyl Alcohol in Patients with Refractory Solid Malignancies (Summary Last Modified 04/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				FCCC-96081 NCI-T96-0061H, T96-0061

Last Modified: 6/1/1999


10.		Phase I Study of Perillyl Alcohol in Patients With Malignancies Who Have Failed Standard Therapy or For Whom No Standard Therapy Exists (Summary Last Modified 06/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				WCCC-CO-9694 NCI-T96-0062, T96-0062

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute